PAUL V. MAIER

Insider Reports History

Location
San Diego, CA
Signature
/s/ Russell Kern, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PAUL V. MAIER:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. Director Ordinary Shares 85K $907K $10.67 07 Jun 2023 Direct
International Stem Cell CORP Director Stock Option (Right to Buy) 533K 17 Jun 2025 Direct
Eton Pharmaceuticals, Inc. Director Stock Option (Right to buy) 165K 13 Feb 2024 Direct
Ambrx Biopharma Inc. Director Stock Option (right to buy) 105K 27 Jan 2023 Direct
Eton Pharmaceuticals, Inc. Director Employee Stock Option (Right to Buy) 25K 03 Jan 2025 Direct
Ambrx Biopharma, Inc. Director Restricted Stock Units 0 07 Mar 2024 Direct
Ambrx Biopharma, Inc. Director Option to Purchase Common Stock 0 07 Mar 2024 Direct

Insider Reports Filed by PAUL V. MAIER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ISCO.OB International Stem Cell CORP 17 Jun 2025 2 $0 4 Director 20 Jun 2025, 08:18
ETON Eton Pharmaceuticals, Inc. 03 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:18
ISCO.OB International Stem Cell CORP 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 16:03
AMAM Ambrx Biopharma, Inc. 07 Mar 2024 3 $0 4 Director 07 Mar 2024, 17:34
ETON Eton Pharmaceuticals, Inc. 13 Feb 2024 1 $0 4 Director 15 Feb 2024, 16:16
ISCO International Stem Cell CORP 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 17:23
AMAM Ambrx Biopharma Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
ETON Eton Pharmaceuticals, Inc. 03 Mar 2023 1 $0 4 Director 03 Mar 2023, 15:10
AMAM Ambrx Biopharma Inc. 27 Jan 2023 4 $0 4 Director 31 Jan 2023, 17:14
AMAM Ambrx Biopharma Inc. 01 Jan 2023 0 $0 3 Director 03 Jan 2023, 17:30
ISCO International Stem Cell CORP 09 Jun 2022 2 $0 4 Director 10 Jun 2022, 17:01
ETON Eton Pharmaceuticals, Inc. 07 Feb 2022 1 $0 4 Director 28 Feb 2022, 15:36
ISCO International Stem Cell CORP 09 Jun 2021 2 $0 4 Director 11 Jun 2021, 14:11